Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05462158 · ClinicalTrials.gov registry record · NA
Message Testing for CKD
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 8,637
- Enrollment target
NCT05462158: Completed NA study, sponsored by University of Pennsylvania.
NCT05462158 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 8,637 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05462158, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,637 participants
- Enrollment target
Study Summary
Members of CVS/Aetna will receive one of two text messages or receive no text message at all. In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." In the Checked Health condition, the message will say, "Have you checked your kidney health recently? By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life. Schedule a doctor visit today to ask about them." There will also be a group of members that do not receive a text message at all.
Interventions
- BEHAVIORAL Impact of Nudges on CKD Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,637 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05462158
The ClinicalTrials.gov registry entry for NCT05462158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,637 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Impact of Nudges on CKD Testing is the first listed.
NCT05462158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05462158 about?
NCT05462158 is a clinical study titled "Message Testing for CKD". Members of CVS/Aetna will receive one of two text messages or receive no text message at all. In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members. By taking them, you could stay ahead of any problem...
What is the current status of trial NCT05462158?
This trial is currently completed. It is a NA study. The enrollment target is 8,637 participants. The study started on 2022-03-15. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05462158?
The interventions under investigation include: Impact of Nudges on CKD Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05462158?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.